MarketCap
Facebook
X
Telegram
Inogen Interest Expense | INGN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.44 M | 850 K | 468 K | -862 K | -710 K | 5.84 M | -229 K | -696 K | 1.3 M | 6 K | 22 K | 449 K | 562 K | 493 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.84 M | -862 K | 710 K |
Quarterly Interest Expense Inogen
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 231 K | -42 K | 606 K | 701 K | 356 K | - | 687 K | 134 K | 143 K | - | -398 K | 337 K | 237 K | - | -12 K | -722 K | -433 K | - | -466 K | 304 K | -310 K | - | -54 K | 5.7 M | -60 K | - | -503 K | 145 K | -120 K | - | 8 K | -1.05 M | 444 K | - | 264 K | 523 K | 207 K | - | 1 K | 2 K | 3 K | - | 5 K | 6 K | 7 K | - | 104 K | 203 K | 133 K | - | 113 K | 95 K | 104 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.7 M | -1.05 M | 186 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M |  USA |
 |
Boston Scientific Corporation
BSX
|
349 M | $ 43.92 | 0.06 % | $ 65 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-3.76 M | $ 8.52 | 0.06 % | $ 621 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
-146 K | $ 14.83 | 1.51 % | $ 420 M | USA |
 |
CONMED Corporation
CNMD
|
31.1 M | $ 45.38 | 0.44 % | $ 1.41 B | USA |
 |
Delcath Systems
DCTH
|
-70 K | $ 15.6 | 0.75 % | $ 559 M | USA |
 |
Eargo
EAR
|
549 K | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
455 K | $ 27.88 | 0.07 % | $ 230 M | USA |
 |
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | USA |
 |
Establishment Labs Holdings
ESTA
|
5.82 M | $ 65.97 | 0.59 % | $ 1.95 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 86.29 | 0.66 % | $ 50.5 B | USA |
 |
Nemaura Medical
NMRD
|
-6.41 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.94 | 1.38 % | $ 64.8 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-274 K | $ 5.64 | 1.26 % | $ 762 M | USA |
 |
InMode Ltd.
INMD
|
4.71 M | $ 14.26 | 0.49 % | $ 922 M | Israel |
 |
Inspire Medical Systems
INSP
|
-2.66 M | $ 70.5 | 2.46 % | $ 2.07 B | USA |
 |
IRadimed Corporation
IRMD
|
164 K | $ 85.76 | 0.66 % | $ 1.09 B | USA |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
AxoGen
AXGN
|
167 K | $ 43.39 | 0.16 % | $ 2 B | USA |
 |
Align Technology
ALGN
|
7.68 M | $ 146.78 | 0.79 % | $ 10.6 B | USA |
|
LENSAR
LNSR
|
636 K | $ 6.92 | 0.28 % | $ 82.7 M | USA |
 |
Sientra
SIEN
|
9.11 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
6.87 M | - | - | $ 1.07 B | USA |
 |
Medtronic PLC
MDT
|
384 M | $ 88.64 | 0.98 % | $ 114 B | USA |
 |
MiMedx Group
MDXG
|
-558 K | $ 4.67 | 0.1 % | $ 690 M | USA |
 |
Surgalign Holdings
SRGA
|
1.01 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
6.9 M | - | - | $ 12.3 B | USA |
 |
Myomo
MYO
|
-668 K | $ 1.61 | 0.6 % | $ 67.4 M | USA |
 |
InspireMD
NSPR
|
200 K | $ 0.7 | 0.71 % | $ 45 M | Israel |
 |
Orthofix Medical
OFIX
|
8.11 M | $ 9.44 | 3.06 % | $ 374 M |  Curacao |
 |
Outset Medical
OM
|
14 M | $ 3.05 | 1.29 % | $ 46.4 K | USA |
 |
Insulet Corporation
PODD
|
14.3 M | $ 136.13 | 0.26 % | $ 9.58 B | USA |
 |
Quanterix Corporation
QTRX
|
157 K | $ 3.27 | 2.83 % | $ 139 M | USA |
 |
Titan Medical
TMDI
|
1.09 M | - | -26.32 % | $ 19.6 M | Canada |
 |
AVITA Medical
RCEL
|
5 M | $ 11.84 | 2.25 % | $ 330 M |  Australia |
 |
Natus Medical Incorporated
NTUS
|
1.87 M | - | 1.94 % | $ 1.05 B | USA |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
-161 K | $ 2.96 | 4.59 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
31 K | $ 1.88 | 0.53 % | $ 5.21 M | USA |
 |
Smith & Nephew plc
SNN
|
140 M | $ 26.91 | 0.86 % | $ 23.3 B | Britain |
 |
Accuray Incorporated
ARAY
|
5.01 M | $ 0.22 | 1.84 % | $ 27 M | USA |
 |
Inari Medical
NARI
|
196 K | - | - | $ 4.23 B | USA |
 |
Sensus Healthcare
SRTS
|
683 K | $ 2.94 | 1.03 % | $ 48 M | USA |
 |
Bruker Corporation
BRKR
|
-46.2 M | $ 64.18 | 0.28 % | $ 9.74 B | USA |